www.marketwatch.com Open in urlscan Pro
13.32.121.65  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main content


MARKETWATCH SITE LOGO A LINK THAT BRINGS YOU BACK TO THE HOMEPAGE.

 * Latest
 * Coronavirus
 * Watchlist
 * Markets
 * Investing
 * Barron's
 * Personal Finance
 * Economy
 * Retirement
 * How to Invest
 * Video Center
 * Live Events
 * Opinion
 * More
   Latest Coronavirus Watchlist Markets Investing Barron's Personal Finance
   Economy Retirement How to Invest Video Center Live Events Opinion


 * Account Settings
 * Log In
 * Sign Up


ASML LIFTS LONG-TERM OUTLOOK, SEES $28- $35 BILLION IN REVENUE BY 2025





Advertisement

Advertisement

 * Home
 * Latest News
 * Watchlist
 * Market Data Center
    * U.S.
    * Cryptocurrency
    * Europe
    * Rates
    * Asia
    * Futures
    * Currencies

 * Markets
    * U.S. Markets
    * Canada
    * Europe & Middle East
    * Asia
    * Emerging Markets
    * Latin America
    * Market Data

 * Investing
    * Barron's
    * Best New Ideas
    * Stocks
    * IPOs
    * Mutual Funds
    * ETFs
    * Options
    * Bonds
    * Commodities
    * Currencies
    * Cryptocurrencies
    * Futures
    * Financial Adviser Center
    * Cannabis
    * Newswires

 * Barron's
 * Economy & Politics
    * Washington Watch
    * Inflation
    * Coronavirus
    * The Federal Reserve
    * Economic Report
    * Rex Nutting
    * U.S. Economic Calendar
    * Coronavirus Recovery Tracker

 * Personal Finance
    * The Moneyist
    * Spending & Saving
    * Retirement
    * TaxWatch
    * Credit Cards
    * Careers
    * Travel
    * Real Estate
    * Real Estate Listings

 * Retirement
    * Best New Ideas in Retirement
    * Estate Planning
    * Help Me Retire
    * FIRE
    * Taxes
    * Social Security
    * Real Estate
    * Retirement Calculator
    * NewRetirement Planner
    * Where Should I Retire
    * Best Places

 * How to Invest
 * Virtual Stock Exchange
 * Video
    * SectorWatch
    * The Moneyist
    * Getting to Work With
    * Love & Money
    * Explainomics
    * Good Company

 * Podcasts
 * Live Events
 * MarketPlace
    * Shop
    * Online Courses
    * Mortgages
    * Consumer Products
    * Loans
    * Insurance

 * Opinion
 * Investor's Business Daily
    * Leaderboard
    * SwingTrader
    * MarketSmith
    * IBDLive

 * Newsletter Center
 * Research & Tools
    * Watchlist
    * Mortgage Calculator
    * Multiple Quotes Tool
    * Stock Screener
    * Earnings Calendar
    * Market Screener
    * IPO Calendar
    * Short Interest
    * Premarket Screener
    * Options Calendar
    * After Hours Screener
    * Currency Tools
    * Mutual Fund Screener
    * Upgrades & Downgrades
    * Mutual Fund Comparison
    * Economic Calendar
    * Where Should I Retire?
    * Savings Accounts
    * Retirement Planner
    * CDs
    * Mortgage Rates

Sign Up Log In
 * Profile Settings
 * Watchlist
 * Email & Alerts
 * Games




Advertisement
 1. Home
 2. Personal Finance


‘I’M A FIRM BELIEVER IN SCIENCE, BUT I’D STILL LIKE TO WAIT’: PFIZER’S VACCINE
RESULTS FOR KIDS MIGHT NOT LEAD TO QUICK VACCINATIONS

Last Updated: Sept. 21, 2021 at 11:42 a.m. ET First Published: Sept. 20, 2021 at
3:47 p.m. ET
By

ANDREW KESHNER

  Comments


4 IN 10 PARENTS OF CHILDREN AGES 5 TO 11 SAY THEY’LL TAKE A ‘WAIT AND SEE’
APPROACH BEFORE THEY HAVE THEIR KIDS VACCINATED, ACCORDING TO A SURVEY FROM THE
KAISER FAMILY FOUNDATION.

PARENTS OF YOUNG KIDS MAY BE ABLE TO HAVE THEIR YOUNG CHILDREN VACCINATED SOON.
ELEMENTARY SCHOOL-AGE KIDS BECAME ONE STEP CLOSER TO VACCINATION ELIGIBILITY
THIS WEEK WHEN PFIZER AND BIONTECH ANNOUNCED THEIR VACCINE IS SAFE AND WELL
TOLERATED BY THE 5- TO 11-YEAR-OLD DEMOGRAPHIC.

Photo by Chandan Khanna/AFP via Getty Images
 * Email icon
 * Facebook icon
 * Twitter icon
 * Linkedin icon
 * Flipboard icon

 * Print icon
 * Resize icon


REFERENCED SYMBOLS


Advertisement
PFE
-1.22%
BNTX
-9.95%

Your browser does not support the audio tag.
Listen to article
Length 7 minutes
AD
Loading advertisement...
00:00 / 07:16
1x

This feature is powered by text-to-speech technology. Want to see it on more
articles?
Give your feedback below or email audiofeedback@marketwatch.com.
thumb-stroke-mediumthumb-stroke-medium

James Lopez got his COVID-19 shots as soon as he could, starting the vaccination
process in March after an infection earlier in the year gave him a first-hand
look at how scary the virus could be.

He’s taking a different approach with his three sons.

Almost two months after the Food and Drug Administration said 12- to
15-year-olds could receive the Pfizer/BioNTech vaccine, his 14-year-old son
Jaiden got his first shot. Jaiden received his second shot in early August,
Lopez said.


Advertisement

Lopez also wants to ease into the process for his 5- and 8-year-old boys.

“I’m a firm believer in science, but I would still like to wait,” Lopez, a
41-year-old New York City resident, told MarketWatch. Though Lopez said he hates
to put it like this, “I want to see how it affects other kids first, how it runs
its course.”

Even though doctors say there is a greater risk of spreading the coronavirus to
those who already have the vaccine if you are unvaccinated, Lopez said he’d do
“anything to keep them safe, but I can’t just be the first in line.”



On Monday morning, elementary school-age kids became now one step closer to
vaccination eligibility when Pfizer PFE, -1.22% and BioNTech BNTX, -9.95%
announced the vaccine is safe and well tolerated by the 5- to 11-year-old
demographic.

JAMES LOPEZ AND HIS SONS ON THE FIRST DAY BACK TO SCHOOL THIS YEAR.

Photo courtesy James Lopez

The companies said they plan to share the data with the FDA and other regulators
as soon as possible — especially since the delta variant is fueling a surge in
all cases and a surge in children’s cases particularly.


Advertisement

“Since July, pediatric cases of COVID-19 have risen by about 240% in the U.S. —
underscoring the public-health need for vaccination,” Albert Bourla, Pfizer’s
chairman and CEO said in a statement.

“These trial results provide a strong foundation for seeking authorization of
our vaccine for children 5 to 11 years old, and we plan to submit them to the
FDA and other regulators with urgency,” he added.



On Friday, an FDA panel recommended a third shot of the Pfizer/BioNTech vaccine
for people ages 65 and people with high-risk conditions. The panel voted against
a third shot for the general public.

Earlier this month, Dr. Rochelle Walensky, director of the Centers for Disease
Control and Prevention, said a vaccine for kids under 12 could roll out to the
public by the end of the year.

But as the companies and public-health officials estimate when vaccines will
become available for kids, they better account for parents like Lopez — and at
least some polls suggest there’s a lot of them.

‘WAIT AND SEE’

A sizable minority — 4 in 10 parents of children ages 5 to 11 — say they’ll take
a “wait and see” approach before they have their children vaccinated, according
to a survey from the Kaiser Family Foundation.

Another 26% will do it “right away,” while 25% say they will “definitely not”
make their children get the shots. Nine percent said their child would only get
the shot if required, according to the poll conducted from mid-July to early
August.


Advertisement

These attitudes track the general views of the COVID-19 vaccine for all age
groups, said Ashley Kirzinger, associate director for public opinion and survey
research at the Kaiser Family Foundation.

With the prospect of vaccination coming, there’s a quick-moving population and a
resistant population, but there’s the plurality that want to see others take the
leap first.

“As they are seeing friends, family members, kids’ classmates get vaccinated
with minimal side effects, they decide to get vaccinated initially for
themselves, and then their children,” Kirzinger said.

The flip side is if parents talk to other parents who aren’t vaccinating their
children, that could lower the prospect of vaccination, she noted.

“The number of COVID-19 vaccinated kids — younger and older — has serious
implications for public health.”

By the end of July, more than 42% of all teens, ages 12 to 17, received at least
one shot, according to the CDC and almost 32% were fully vaccinated.

The number of COVID-19 vaccinated kids — younger and older — has serious
implications for public health. But it also counts for schools and the parents
who have to juggle jobs with issues like their child’s supervision if the
student has to quarantine due to infection of close contact with a fellow
student.


Advertisement

Kaiser Family Foundation researchers are doing new polling on the topic and one
question is whether the delta variant’s rise will nudge more parents into a
quicker vaccination pace for their kids, she noted.

A recent study also showed a cautious parent approach. Between February and
March, one third of parents said their child’s COVID-19 vaccination was “very
unlikely” and 9% said it was “somewhat unlikely,” according to an article
published in Pediatrics.

On the other end of the spectrum, 28% of parents said their child’s COVID-19
vaccination was “very likely” and 18% said it was “somewhat likely,” according
to the research from 1,745 parents. Meanwhile, 12% were unsure, the study said.

“The known risks of vaccines ‘far outweigh the potential risks of having a rare
adverse reaction to vaccination.’”

— Centers for Disease Control and Prevention

Ideally, Lopez said he too would like to wait about two months before his two
younger sons would get their COVID-19 shots. That would be ample time to see how
other kids and families are faring, said Lopez, the owner of Cool4Dads.com, a
website that’s geared towards fathers, connecting them with activities and
events.


Advertisement

Lopez said that many of the parents he talks to in his line of work say they are
aren’t planning to immediately vaccinate their kids.

For example, before Jaiden’s vaccination Lopez and his wife waited to hear more
about myocarditis, inflammation of the heart muscle, and pericarditis, which is
when inflammation of lining outside the heart occurs.

The Centers for Disease Control and Prevention has said there have been rare
cases of the condition for male teens and young adults, more often after the
second dose.

However, an article in the British Medical Journal said at least one such study
that  claimed boys are at increased risk of myocarditis after receiving a
COVID-19 vaccination was deeply flawed.

“The study has been widely criticized for mining data from an inappropriate
source to deliver an anti-vaccine message, despite warnings against such data
uses,” the article said.

Still, the “known risks” of COVID-19 “far outweigh the potential risks of having
a rare adverse reaction to vaccination, including the possible risk of
myocarditis or pericarditis,” the CDC said.

“The 10 ug [microgram] dose was carefully selected as the preferred dose for
safety, tolerability and immunogenicity in children 5 to 11 years of age,”
Pfizer and BioNTech said in a statement on Monday. “These are the first results
from a pivotal trial of a COVID-19 vaccine in this age group.” 

Lopez is ready to move quicker now if he has to. If a COVID-19 case surge
intensifies in the future, that might push his timeline.

Similarly, if changes in school rules make life easier for vaccinated kids and
parents — like changes to quarantine policies for students in close contact with
infected students — he’d push up vaccination timelines as well.

“If my hands are forced, we already have it,” Lopez noted. “I can’t really argue
against it.”


READ NEXT


READ NEXT


NEW YORK HEALTH-CARE WORKERS WHO ARE FIRED FOR REFUSING TO BE VACCINATED WON’T
BE ELIGIBLE FOR UNEMPLOYMENT BENEFITS — IN MOST CASES

Hospital, adult care and long-term care workers had until Monday to get an
initial COVID-19 vaccine dose.


MORE ON MARKETWATCH

 * Here’s exactly how much economists think home prices will rise in 2022 — and
   whether you should buy now
 * Belize could be the new Bahamas for vacation homes
 * You could buy NFL legend Emmitt Smith’s Dallas mansion for $2.2 million — and
   get a private dinner with him
 * Bank robbers stole $600K after kidnapping branch workers they followed home
   with tracking devices


Advertisement
Community Guidelines • FAQs

Advertisement

Advertisement

PARTNER CENTER


Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

MOST POPULAR


Advertisement

REAL-ESTATE INVESTORS ARE LESS OPTIMISTIC ABOUT THE U.S. HOUSING MARKET — HERE’S
WHY

WHAT HAPPENS IF THE U.S. DEFAULTS ON ITS DEBT?

ONLY 47 STOCKS IN THE S&P 500 HAVE FALLEN OVER THE PAST YEAR — WALL STREET
PREDICTS THEY WILL CLIMB UP TO 54% IN 12 MONTHS

GOLD IS AT HISTORICAL HIGHS - HERE'S WHAT INVESTORS NEED TO KNOW

NETFLIX SAYS ‘BRIDGERTON’ IS ITS MOST-WATCHED SERIES EVER — BUT MAYBE NOT FOR
LONG


Advertisement




PARTNER CONTENT




PARTNER CONTENT



Back to Top
MarketWatch logoGo to the homepage
Copyright © 2021 MarketWatch, Inc. All rights reserved.
By using this site you agree to the Subscriber Agreement & Terms of Use, 
Privacy Notice, and Cookie Notice.
 * Facebook
 * Twitter
 * Linkedin
 * 

 * MARKETWATCH

 * Customer Center
 * Contact Us
 * Newsroom Roster
 * Virtual Stock Exchange
 * BigCharts
 * Copyright Policy
 * Manage Notifications

 * COMPANY

 * Dow Jones
 * Code of Conduct
 * Corrections
 * Reprints & Licensing
 * Your Ad Choices
 * Corporate Subscriptions

 * DOW JONES NETWORK

 * The Wall Street Journal
 * Barron's
 * Financial News London
 * realtor.com
 * Mansion Global

Intraday Data provided by FACTSET and subject to terms of use. Historical and
current end-of-day data provided by FACTSET. All quotes are in local exchange
time. Real-time last sale data for U.S. stock quotes reflect trades reported
through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange
requirements.



Advanced Search Submit entry for keyword results

Advertisement



LISTINGS




COLUMNS




AUTHORS




TOPICS





PRIVATE

No results found